|
|
regulation of transforming growth factor beta secretion
|
GO:2001201 |
1 |
0.991
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.970
|
|
|
|
positive regulation of transforming growth factor beta secretion
|
GO:2001203 |
1 |
0.966
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.430
|
Mouse |
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.375
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.318
|
Mouse |
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.295
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.270
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.256
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.247
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
6 |
0.231
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.220
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.202
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.199
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.194
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.194
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.175
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.170
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.168
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.161
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.160
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.160
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.154
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.147
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.145
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.145
|
Mouse |
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.142
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.131
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.131
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.128
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.126
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.125
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.122
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.119
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.115
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.115
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.114
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.113
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.112
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.109
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.108
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.107
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.099
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.094
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.094
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.093
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.091
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.090
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.090
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.090
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.090
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.087
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.085
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.082
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.081
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.079
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.079
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.079
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.076
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.074
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.073
|
Mouse |
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.070
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.070
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.068
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.067
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.067
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.066
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.066
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.066
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.065
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.064
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.064
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.062
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.059
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.059
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.058
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.057
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.056
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.056
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.055
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.055
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.054
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.053
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.052
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.052
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.051
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.051
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.050
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.049
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.049
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.049
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.049
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.048
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.048
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.048
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.048
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.047
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.047
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.047
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.045
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.044
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.044
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.044
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.044
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.044
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.044
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.043
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.043
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.043
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.043
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.042
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.042
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.042
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.042
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.042
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.042
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.041
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.041
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.041
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.040
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.040
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.040
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.040
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.039
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.039
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.039
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.038
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.038
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.038
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.038
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.038
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.038
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.037
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.037
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.037
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.037
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.036
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.036
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.035
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.035
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.035
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.035
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.035
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.035
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.035
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.035
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.034
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.034
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.034
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.034
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.033
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.033
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.033
|
|
|
|
cellular magnesium ion homeostasis
|
GO:0010961 |
3 |
0.033
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.032
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.032
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.032
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.032
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.032
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.031
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.031
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.031
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.031
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.031
|
|
|
|
regulation of oligodendrocyte differentiation
|
GO:0048713 |
23 |
0.030
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.030
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.030
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.030
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.030
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.030
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.030
|
Mouse |
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.030
|
|
|
|
platelet formation
|
GO:0030220 |
12 |
0.030
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.030
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.029
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.029
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.029
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.029
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.029
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.029
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.029
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.028
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.028
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.028
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.028
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.028
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.028
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.027
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.027
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.027
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.027
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.027
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.027
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.027
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.027
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.027
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.026
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.026
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.026
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.026
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.026
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.026
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.026
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.026
|
|
|
|
positive regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000451 |
2 |
0.026
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.026
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.025
|
|
|
|
regulation of interleukin 10 production
|
GO:0032653 |
21 |
0.025
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.025
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.025
|
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
15 |
0.025
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.025
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.025
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.025
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.025
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.025
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.025
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.025
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.025
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.025
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.025
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.024
|
|
|
|
epithelial structure maintenance
|
GO:0010669 |
9 |
0.024
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.024
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.024
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.024
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.024
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.023
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.023
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.023
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.023
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.023
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.023
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.023
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.023
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.023
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.023
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.022
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.022
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.022
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.022
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.022
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.022
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.022
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.022
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.022
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.022
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.022
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.022
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.022
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.022
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.021
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.021
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.021
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.021
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.021
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.021
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.021
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.021
|
|
|
|
regulation of monocyte extravasation
|
GO:2000437 |
2 |
0.020
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.020
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.020
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.020
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.020
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.020
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.020
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.020
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.020
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.020
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.020
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.020
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.020
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.020
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.020
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.020
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.020
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.020
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.020
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.020
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.019
|
|
|
|
camera type eye photoreceptor cell differentiation
|
GO:0060219 |
15 |
0.019
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.019
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.019
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.019
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.019
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.019
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.019
|
|
|
|
positive regulation of monocyte extravasation
|
GO:2000439 |
1 |
0.019
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.019
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.019
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.019
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.019
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.019
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.019
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.018
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.018
|
Mouse |
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.018
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.018
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.018
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.018
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.018
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.018
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.018
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.018
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.018
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.018
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.018
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.018
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.018
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.018
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.018
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.018
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.017
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.017
|
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.017
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.017
|
|
|
|
negative regulation of biomineral tissue development
|
GO:0070168 |
11 |
0.017
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.017
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.017
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.017
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.017
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.017
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.017
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.017
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.017
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.017
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.017
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.017
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
23 |
0.017
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.017
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.017
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.017
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.017
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.017
|
|
|
|
interleukin 10 production
|
GO:0032613 |
23 |
0.017
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.017
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.017
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.016
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.016
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.016
|
|
|
|
primitive hemopoiesis
|
GO:0060215 |
7 |
0.016
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.016
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.016
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.016
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.016
|
|
|
|
face development
|
GO:0060324 |
38 |
0.016
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.016
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.016
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.016
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.016
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.016
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.016
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.016
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.016
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.016
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.016
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.016
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.016
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.016
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.015
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.015
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.015
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.015
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.015
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.015
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.015
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.015
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.015
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.015
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.015
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.015
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.015
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.015
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.015
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.015
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.015
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.015
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.015
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.015
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.015
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.015
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.015
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.015
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.015
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.015
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.014
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.014
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
1 |
0.014
|
|
|
|
positive regulation of epidermal cell differentiation
|
GO:0045606 |
6 |
0.014
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.014
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.014
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.014
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.014
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.014
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.014
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.014
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.014
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.014
|
|
|
|
generation of ovulation cycle rhythm
|
GO:0060112 |
1 |
0.014
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.014
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.014
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.014
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.014
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.014
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.014
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.014
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.014
|
|
|
|
positive regulation of mitochondrial calcium ion concentration
|
GO:0051561 |
3 |
0.014
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.014
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.014
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.014
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.014
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.014
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.013
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.013
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.013
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.013
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.013
|
|
|
|
regulation of interleukin 4 biosynthetic process
|
GO:0045402 |
3 |
0.013
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.013
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.013
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.013
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.013
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.013
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.013
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.013
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.013
|
|
|
|
behavioral defense response
|
GO:0002209 |
28 |
0.013
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.013
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.013
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.013
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.013
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.013
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.013
|
|
|
|
regulation of hematopoietic stem cell migration
|
GO:2000471 |
1 |
0.013
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.013
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
28 |
0.013
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.013
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.013
|
|
|
|
regulation of translational initiation in response to stress
|
GO:0043558 |
5 |
0.013
|
Mouse |
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.013
|
|
|
|
positive regulation of immunological synapse formation
|
GO:2000522 |
1 |
0.013
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.013
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.013
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.013
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.013
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.013
|
|
|
|
transepithelial chloride transport
|
GO:0030321 |
4 |
0.013
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.013
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.013
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.013
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.013
|
|
|
|
eosinophil activation involved in immune response
|
GO:0002278 |
1 |
0.013
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.013
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.013
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
18 |
0.013
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.013
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
|
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation
|
GO:2000526 |
1 |
0.013
|
|